Stock Events

Stock Events

AMGEN 

$459.65
3951
-$17.39-3.65%Friday 07:49

Statistics

Day High
459.65
Day Low
453
52W High
480.19
52W Low
323.44
Volume
10,080
Avg. Volume
-
Mkt Cap
248.5B
P/E Ratio
-
Dividend Yield
2.19%
Dividend
10.08

Upcoming

Dividends

2.19%Dividend Yield
Sep 2026
$2.52
Jun 2026
$2.52
Mar 2026
$2.52
Dec 2025
$2.38
Sep 2025
$2.38
10Y Growth
10.12%
5Y Growth
7.64%
3Y Growth
6.07%
1Y Growth
5.86%

Earnings

Feb 9Expected
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Q3 2026
Next
4.73
5.31
5.88
6.45
Expected EPS
5.651481
Actual EPS
N/A

Financials

20.98%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
36.75BRevenue
7.71BNet Income

Analyst Ratings

$448.71Average Price Target
The highest estimate is ⁦536.00⁩.
From 21 ratings within the last 6 months. This is not an investment recommendation.
Buy
38%
Hold
62%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow AMGN.BOATS. It's not an investment recommendation.
Abbvie
953
ABBV
Microsoft
881
MSFT
Apple
840
AAPL
Realty Income
785
O

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Gilead Sciences
GILD
Mkt Cap211.7B
Gilead Sciences competes in the biopharmaceutical sector focusing on antiviral drugs, similar therapeutic areas as Amgen.
Abbvie
ABBV
Mkt Cap521.11B
AbbVie operates in the same biopharmaceutical space, with a strong presence in immunology and oncology, directly competing with Amgen's product lines.
Bristol-Myers Squibb
BMY
Mkt Cap127.71B
Bristol Myers Squibb is a major player in the biopharmaceutical industry, with a focus on cancer and immune system disorders, overlapping with Amgen's market.
Pfizer
PFE
Mkt Cap173.95B
Pfizer is a global pharmaceutical company with a broad range of products that compete across several of Amgen's key therapeutic areas.
Merck
MRK
Mkt Cap368.89B
Merck & Co. focuses on pharmaceuticals including oncology, vaccines, and animal health, competing with Amgen in the oncology and biologic drugs market.
Johnson & Johnson
JNJ
Mkt Cap657.68B
Johnson & Johnson, through its pharmaceutical division Janssen, competes in the immunology and oncology sectors, similar to Amgen.
Regeneron Pharmaceuticals
REGN
Mkt Cap95.99B
Regeneron Pharmaceuticals specializes in biopharmaceuticals, particularly in monoclonal antibodies, a direct competitor to Amgen's biologic treatments.
Novartis
NVS
Mkt Cap303.67B
Novartis is a global healthcare company that competes with Amgen in several areas, including biopharmaceuticals and generic drugs.
Rogers
ROG
Mkt Cap2.37B
Roche Holding AG, with its strong focus on oncology and immunotherapy, competes directly with Amgen in the biopharmaceutical and diagnostics sectors.
Sanofi
SNY
Mkt Cap106.24B
Sanofi operates globally in the pharmaceutical sector, with a focus on diabetes, oncology, and rare diseases, areas where Amgen also has significant interests.

About

Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drugs Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx Pharmaceuticals bolstered the firm's therapeutic oncology portfolio with Kyprolis, which has been further strengthened with the launch of new drugs in blood cancers (Blincyto) and solid tumors (Imdelltra). The 2023 Horizon acquisition brought several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.
Show More
CEO
ISIN
US0311621009

Listings

XNAS
US
AMGN
F
DE
AMG0.F
STU
DE
AMG.STU
SN
CL
AMGN.SN

0 Comments

Share your thoughts

FAQs

What is AMGEN stock price today?▼
The current price of AMGN.BOATS is $459.65 USD — it has decreased by -3.65% in the past 24 hours. Watch AMGEN stock price performance more closely on the chart.
What is AMGEN stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boats exchange AMGEN stocks are traded under the ticker AMGN.BOATS.
What is AMGEN market cap?▼
Today AMGEN has the market capitalization of 248.5B
When is the next AMGEN earnings date?▼
AMGEN is going to release the next earnings report on February 9, 2027.
What were AMGEN earnings last quarter?▼
AMGN.BOATS earnings for the last quarter are 6.45 USD per share, whereas the estimation was 5.79 USD resulting in a +11.47% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is AMGEN revenue for the last year?▼
AMGEN revenue for the last year amounts to 36.75B USD.
What is AMGEN net income for the last year?▼
AMGN.BOATS net income for the last year is 7.71B USD.
Does AMGEN pay dividends?▼
Yes, AMGN.BOATS dividends are paid quarterly. The last dividend per share was 2.52 . As of today, Dividend Yield (FWD)% is 2.19%.
In which sector is AMGEN located?▼
AMGEN operates in the Other sector.
When did AMGEN complete a stock split?▼
AMGEN has not had any recent stock splits.